CBD oil for anorexia?
Eating disorders & CBD
Cannabinoids as an integral part of our diet is a concept that is gaining great interest, with great focus for the treatment of eating disorders such as anorexia, bulimia and cachexia. Cannabinoids such as CBD have been shown to be compounds with multi-modal action mechanisms, with clear therapeutic potential in different medical areas. One of the strongest points for the basis of the use of CBD is its high tolerability in humans, whose bioavailability in the form of CBD oils is becoming the most attractive application form.
How Is Anorexia Defined?
Anorexia is defined as an eating disorder characterized by a very restricted food intake, to the point of starvation and severe self-inflicted weight loss, also entailing an abnormal perception of the patient’s body image.
Among this disorder, two central types have been identified:
- Bulimic Subtype: Use of laxatives, induction to vomit, diuretics and intense exercise to achieve the loss of body weight.
- Restrictive Subtype: The patient tends to limit his intake of calories and food to the extreme to achieve the loss of body weight.
This disease is of special complication when dealing with patients diagnosed with cancer in advanced stages, coming to be considered as critical limiting factors for the quality of life of patients, even over the chronic or intense pain that can result from therapies such as chemotherapy or radiotherapy.
Anorexia has a combination of very different factors for its appearance, among which biological, psychological and above all, social factors are those that most affect individuals: Obesity of one of the parents, academic failures, separation of parents, or traumatic events, are just some examples of the triggers for the appearance of this disorder.
The factors capable of affecting the development of this disorder are complex and not fully understood to this day.
Phyto cannabinoids As Novel Agents Against Eating Disorders
Cannabidiol (CBD) as one of the main Phyto cannabinoids has generated a solid body of evidence in preclinical and clinical studies to be used as a potential therapeutic alternative in different models of diseases and chronic disorders (cancer, epilepsy, anorexia, diabetes, etc.). )
It is important to note that high concentrations of CBD administration, it has been found that CBD is very well tolerated. This is another of the bases for the promising effectiveness of cannabinoids in disease models such as anorexia. An anxiolytic effect could rid the patient of the constant worry he has when he ingests the necessary foods, and allow him not to focus on negative self-destructive behaviors (vomiting, purging).
Compounds with the ability to activate CB1 receptors can lead to an appetite stimulation, thus increasing the value of CBD as a candidate for the modulation and regulation of these receptors found in our Endocannabinoid System.
Finally, it is always important to mention that among the properties of the CBD, it has its capacity to deny the psychotropic effects of its cannabinoid counterpart known as THC. In other words, use of CBD will not produce such effects.